<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Therapy</journal-id><journal-title-group><journal-title xml:lang="en">Therapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапия</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2412-4036</issn><issn publication-format="electronic">2713-1823</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">717608</article-id><article-id pub-id-type="doi">10.18565/therapy.2026.5.154-163</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>LECTURES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Diagnosis of extraintestinal manifestations of inflammatory bowel disease: A review</article-title><trans-title-group xml:lang="ru"><trans-title>Диагностика внекишечных проявлений воспалительных заболеваний кишечника: обзор</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1496-0689</contrib-id><contrib-id contrib-id-type="spin">4125-7935</contrib-id><name-alternatives><name xml:lang="en"><surname>Tarasova</surname><given-names>Larisa V.</given-names></name><name xml:lang="ru"><surname>Тарасова</surname><given-names>Лариса Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), professor, head of the Department of hospital therapy</p></bio><bio xml:lang="ru"><p>д. м. н., профессор, заведующая кафедрой госпитальной терапии</p></bio><email>tlarisagast18@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8339-9496</contrib-id><contrib-id contrib-id-type="spin">9373-7120</contrib-id><name-alternatives><name xml:lang="en"><surname>Tsyganova</surname><given-names>Yulia V.</given-names></name><name xml:lang="ru"><surname>Цыганова</surname><given-names>Юлия Вадимовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD (Medicine), associate professor of the Department of hospital therapy</p></bio><bio xml:lang="ru"><p>к. м. н., доцент кафедры госпитальной терапии</p></bio><email>j.v.tsyganova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4534-999X</contrib-id><contrib-id contrib-id-type="spin">9895-2042</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikolaev</surname><given-names>Anton A.</given-names></name><name xml:lang="ru"><surname>Николаев</surname><given-names>Антон Андреевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, assistant at the Department of hospital therapy</p></bio><bio xml:lang="ru"><p>ассистент кафедры госпитальной терапии</p></bio><email>anton_nikolaev_2001@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.N. Ulyanov Chuvash State University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Чувашский государственный университет имени И.Н. Ульянова»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2026-08-29" publication-format="electronic"><day>29</day><month>08</month><year>2026</year></pub-date><volume>12</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>154</fpage><lpage>163</lpage><history><date date-type="received" iso-8601-date="2026-08-29"><day>29</day><month>08</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-08-29"><day>29</day><month>08</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, “Bionika Media” LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, ООО «Бионика Медиа»</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">“Bionika Media” LLC</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://journals.eco-vector.com/2412-4036/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/2412-4036/article/view/717608">https://journals.eco-vector.com/2412-4036/article/view/717608</self-uri><abstract xml:lang="en"><p>Current study is devoted to the analysis of clinical and laboratory approaches to diagnosing extraintestinal manifestations of inflammatory bowel disease (IBD). According to the review, IBD diagnosis is currently based primarily on clinical assessment, physical examination data, instrumental research methods, and the use of standardized classification criteria, while laboratory methods are auxiliary and primarily used for differential diagnostic purposes. Moreover, data of scientific literature demonstrates the systemic nature of IBD and points out to the potential for further exploration of non-invasive biomarkers reflecting the activity of extraintestinal manifestations and disease prognosis. Studying immune-inflammatory mechanisms underlying systemic lesions in case of IBD, as well as assessing the potential of extraintestinal manifestations as predictors of the underlying disease, may contribute to the improvement of diagnostic and therapeutic strategies in this patient population.</p></abstract><trans-abstract xml:lang="ru"><p>Настоящая работа посвящена анализу клинических и лабораторных подходов к диагностике внекишечных проявлений воспалительных заболеваний кишечника (ВЗК). Согласно данным проведенного обзора, в настоящее время диагностика ВЗК базируется преимущественно на клинической оценке, данным физикального обследования, инструментальных методов исследования и использовании стандартизированных классификационных критериев, тогда как лабораторные методы носят вспомогательный характер и преимущественно применяются с дифференциально-диагностическими целями. При этом сведения научной литературы свидетельствуют о системном характере ВЗК и указывают на перспективность дальнейшего поиска неинвазивных биомаркеров, отражающих активность внекишечных проявлений и прогноз заболевания. Изучение иммуновоспалительных механизмов, лежащих в основе системных поражений при ВЗК, а также оценка потенциала внекишечных проявлений в качестве предикторов течения основного заболевания могут способствовать совершенствованию диагностических и терапевтических стратегий у соответствующей категории пациентов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>inflammatory bowel disease</kwd><kwd>extraintestinal manifestations of inflammatory bowel disease</kwd><kwd>inflammatory bowel disease biomarkers</kwd><kwd>endothelial dysfunction</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>воспалительные заболевания кишечника</kwd><kwd>внекишечные проявления воспалительных заболеваний кишечника</kwd><kwd>биомаркеры воспалительных заболеваний кишечника</kwd><kwd>эндотелиальная дисфункция</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Gordon H, Burisch J, Ellul P, Karmiris K, Katsanos K, Allocca M et al. ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2024;18(1):1–37. PMID: 37351850. https://doi.org/10.1093/ecco-jcc/jjad108</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kaz AM, Venu N. Diagnostic methods and biomarkers in inflammatory bowel disease. diagnostics. Diagnostics (Basel). 2025;15(11):1303. PMID: 40506875. PMCID: PMC12154505. https://doi.org/10.3390/diagnostics15111303</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Клинические рекомендации. Язвенный колит. Общероссийская общественная организация «Ассоциация колопроктологов России», Российская гастроэнтерологическая ассоциация. Рубрикатор клинических рекомендаций Минздрава России. 2025. ID: 193_2. Доступ: https://cr.minzdrav.gov.ru/preview-cr/193_2 (дата обращения – 15.05.2026). [Clinical guidelines. Ulcerative colitis. Association of Coloproctologists of Russia, Russian Gastroenterological Association. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2025. ID: 193_2. URL: https://cr.minzdrav.gov.ru/preview-cr/193_2 (date of access – 15.05.2026) (In Russ.)].</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Клинические рекомендации. Болезнь Крона. Общероссийская общественная организация «Ассоциация колопроктологов России», Российская гастроэнтерологическая ассоциация. Рубрикатор клинических рекомендаций Минздрава России. 2025. ID: 176_2. Доступ: https://cr.minzdrav.gov.ru/preview-cr/176_2 (дата обращения – 15.05.2026). [Clinical guidelines. Crohn’s Disease. Association of Coloproctologists of Russia, Russian Gastroenterological Association. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2025. ID: 176_2. URL: https://cr.minzdrav.gov.ru/preview-cr/176_2 (date of access – 15.05.2026) (In Russ.)].</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106(1):110–19. PMID: 20808297. https://doi.org/10.1038/ajg.2010.343</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Karmiris K, Avgerinos A, Tavernaraki A, Zeglinas C, Karatzas P, Koukouratos T et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016;10(4):429–36. PMID: 26721936. PMCID: PMC4946768. https://doi.org/10.1093/ecco-jcc/jjv232</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Faggiani I, Fanizza J, D’Amico F, Allocca M, Zilli A, Parigi TL et al. Extraintestinal manifestations in inflammatory bowel disease: From pathophysiology to treatment. Biomedicines. 2024;12(8):1839. PMID: 39200303. PMCID: PMC11351332. https://doi.org/10.3390/biomedicines12081839</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Ossum AM, Palm O, Cvancarova M, Solberg IC, Vatn M, Moum B, Hoivik ML; IBSEN study group. Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study. Scand J Gastroenterol. 2018;53(10–11):1250–56. PMID: 30353756. https://doi.org/10.1080/00365521.2018.1518482</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history. Gut. 1998;42(3):387–91. PMID: 9577346. PMCID: PMC1727027. https://doi.org/10.1136/gut.42.3.387</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Arvikar SL, Fisher MC. Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med. 2011;4(3):123–31. PMID: 21710141. PMCID: PMC3261248. https://doi.org/10.1007/s12178-011-9085-8</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Conigliaro P, Chimenti MS, Ascolani M, Triggianese P, Novelli L, Onali S et al. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. Autoimmun Rev. 2016;15(2):184–90. PMID: 26554932. https://doi.org/10.1016/j.autrev.2015.11.002</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Tavassoli S, Shahabinasab I, Norouzi A, Amiriani T, Abdolahi N, Livani S et al. From bowel inflammation to the bone and joints: Musculoskeletal examination in inflammatory bowel disease (IBD). BMC Musculoskelet Disord. 2021;22(1):1019. PMID: 34863148. PMCID: PMC8645134. https://doi.org/10.1186/s12891-021-04903-4</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777–83. PMID: 19297344. https://doi.org/10.1136/ard.2009.108233. Erratum in: Ann Rheum Dis. 2019;78(6):e59. PMID: 19297344. https://doi.org/10.1136/ard.2009.108233corr1</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>D’Inca R, Sturniolo G. Biomarkers in IBD: What to utilize for the diagnosis? Diagnostics (Basel). 2023;13(18):2931. PMID: 37761298. PMCID: PMC10527829. https://doi.org/10.3390/diagnostics13182931</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Sen R, Goyal A, Hurley JA. Seronegative spondyloarthropathy. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459356/</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Edara M, Bhatt V, Zanwar A, Koneru K, Patel AM, Jawade P. A study of clinical, radiological features and HLA-B27 serology of axial spondyloarthropathy with comparison of radiographic and non-radiographic disease. J Family Med Prim Care. 2022;11(8):4417–23. PMID: 36352982. PMCID: PMC9638547. https://doi.org/10.4103/jfmpc.jfmpc_62_22</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Seidman AJ, Limaiem F. Synovial fluid analysis. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537114.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Reddy Mundla GK, Rallapalli R, Galla SS, Ravindran B. A prospective study for diagnosing joint diseases by synovial fluid analysis and percutaneous needle biopsy of synovium. Int J Res Orthop. 2017;3(4):661–69. https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20172544</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Nooh N, Turkawi R, Maybury M, Cardy C, Sahbudin I. Applications of musculoskeletal ultrasound in inflammatory arthritis. Clin Med (Lond). 2025;25(5):100508. PMID: 40914461. PMCID: PMC12546444. https://doi.org/10.1016/j.clinme.2025.100508</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Akhondi H, Blum MA, Gupta N. Polyarticular arthritis. [Updated 2025 Aug 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537170/</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Lacout A, Rousselin B, Pelage J. CT and MRI of spine and sacroiliac involvement in spondyloarthropathy. AJR Am J Roentgenol. 2008;191(4):1016–23. PMID: 18806136. https://doi.org/10.2214/ajr.07.3446</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Vladimirova N, Moller J, Attauabi M, Madsen G, Seidelin J, Terslev L et al. Spine and sacroiliac joint involvement in newly diagnosed patients with inflammatory bowel disease: Clinical and MRI findings from a population-based cohort. Am J Gastroenterol. 2025;120(1):225–40. PMID: 39162769. https://doi.org/10.14309/ajg.0000000000003039</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Ungureanu L, Cosgarea R, Alexandru Badea M, Florentina Vasilovici A, Cosgarea I, Corina Șenila S. Cutaneous manifestations in inflammatory bowel disease (review). Exp Ther Med. 2020;20(1):31–37. PMID: 32508989. PMCID: PMC7271697. https://doi.org/10.3892/etm.2019.8321</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>He R, Zhao S, Cui M, Chen Y, Ma J, Li J, Wang X. Cutaneous manifestations of inflammatory bowel disease: Basic characteristics, therapy, and potential pathophysiological associations. Front Immunol. 2023;14:1234535. PMID: 37954590. PMCID: PMC10637386. https://doi.org/10.3389/fimmu.2023.1234535</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Sahoo RL, Sethi SK, Dalabehera S, Mishra A, Patra R. Dermatological manifestations in inflammatory bowel disease. J Dermatol Case Rep. 2025;18(2):144–51. https://doi.org/10.61705/jdcr.18.2.2025.144.151</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Тарасова Л.В., Краснова Н.В., Гималиева Г.Г., Кольцова И.В., Цыганова Ю.В. Гангренозная пиодермия, язвенная форма как симптом болезни Крона: клинический случай. Клинический разбор в общей медицине. 2025;6(5):114–118. [Tarasova LV, Krasnova NV, Gimalieva GG, Koltsova IV, Tsyganova YuV. Gangrenous pyoderma, ulcerative form as a symptom of Crohn’s disease: A clinical case. Klinicheskiy razbor v obshchey meditsine = Clinical Review for General Practice. 2025;6(5):114–118 (In Russ.)]. EDN: JUOKJG. https://doi.org/10.47407/kr2025.6.5.00621</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: A cohort study of 2402 patients. Medicine (Baltimore). 2008;87(5):281–93. PMID: 18794711. https://doi.org/10.1097/MD.0b013e318187cc9c</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Perez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, Gomez-Flores M. Erythema nodosum: A practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021;22(3):367–78. PMID: 33683567. PMCID: PMC7938036. https://doi.org/10.1007/s40257-021-00592-w</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>George C, Deroide F, Rustin M. Pyoderma gangrenosum – a guide to diagnosis and management. Clin Med (Lond). 2019;19(3):224–28. PMID: 31092515. PMCID: PMC6542232. https://doi.org/10.7861/clinmedicine.19-3-224</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Troncoso LL, Biancardi AL, de Moraes HV Jr, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World J Gastroenterol. 2017;23(32):5836–48. PMID: 28932076. PMCID: PMC5583569. https://doi.org/10.3748/wjg.v23.i32.5836</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Rodriguez Duran M, O’Keefe GAD. Ocular extraintestinal manifestations and treatments in patients with inflammatory bowel disease. Front Ophthalmol (Lausanne). 2024;3:1257068. PMID: 38983096. PMCID: PMC11182217. https://doi.org/10.3389/fopht.2023.1257068</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Arzbecker M, Kopplin LJ. Manifestations and management of inflammatory eye disease in patients with inflammatory bowel disease. Ocul Immunol Inflamm. 2024;32(10):2348–53. PMID: 38848110. https://doi.org/10.1080/09273948.2024.2362881</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Harthan JS, Opitz DL, Fromstein SR, Morettin CE. Diagnosis and treatment of anterior uveitis: Optometric management. Clin Optom (Auckl). 2016;8:23–35. PMID: 30214346. PMCID: PMC6095364. https://doi.org/10.2147/OPTO.S72079</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Pytrus W. Akutko K, Pytrus T, Turno-Krecicka A. A review of ophthalmic complications in inflammatory bowel diseases. J Clin Med. 2022;11(24):7457. PMID: 36556071. PMCID: PMC9781961. https://doi.org/10.3390/jcm11247457</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996;23(1):29–34. PMID: 8835896. https://doi.org/10.1097/00004836-199607000-00009</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Cheung O, Regueiro MD. Inflammatory bowel disease emergencies. Gastroenterol Clin North Am. 2003;32(4):1269–88. PMID: 14696307. https://doi.org/10.1016/s0889-8553(03)00095-5</mixed-citation></ref></ref-list></back></article>
